Extralymphatic virus sanctuaries as a consequence of potent T-cell activation

Nature Medicine

Volumn 13, Issue 11, 2007, Pages 1316-1323

  Recher, Mike ^a   Lang, Karl S ^a   Navarini, Alexander ^a   Hunziker, Lukas ^a,b   Lang, Philipp A ^a   Fink, Katja ^a   Freigang, Stefan ^a   Georgiev, Panco ^a   Hangartner, Lars ^a   Zellweger, Raphael ^a   Bergthaler, Andreas ^a   Hegazy, Ahmed N ^a,c   Eschli, Bruno ^a   Theocharides, Alexandre ^b   Jeker, Lukas T ^b,d   Merkler, Doron ^a,e   Odermatt, Bernhard ^a   Hersberger, Martin ^f   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HELPER CELL; IMMUNE RESPONSE; KIDNEY INTERSTITIUM; LYMPHATIC SYSTEM; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VIRUS; VIRUS INFECTION; VIRUS LOAD; VIRUS NEUTRALIZATION;

ANIMALS; CELL LINE; CRICETINAE; KIDNEY; LIVER; LUNG; LYMPHATIC SYSTEM; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGAN SPECIFICITY; T-LYMPHOCYTES; VIRUS LATENCY; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HEPATITIS C VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MURINAE; MUS;

EID: 35948930165     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1670     Document Type: Article

References (43)

1. Hilleman, M.R. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc. Natl. Acad. Sci. USA 101 Suppl. 2, 14560-14566 (2004).
2. Peterlin, B.M. & Trono, D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat. Rev. Immunol. 3, 97-107 (2003).
3. Alcami, A. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3, 36-50 (2003).
4. Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307-312 (2003).
5. Rehermann, B. & Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5, 215-229 (2005).
6. Fischer, S.A. et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354, 2235-2249 (2006).
7. Bruggeman, L.A. et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J. Am. Soc. Nephrol. 11, 2079-2087 (2000).
8. Arrieta, J.J. et al. In situ detection of hepatitis C virus RNA in salivary glands. Am. J. Pathol. 158, 259-264 (2001).
9. Becker, J.L. et al. Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis. J. Clin. Invest. 104, 1673-1681 (1999).
10. Stewart, J.P., Usherwood, E.J., Ross, A., Dyson, H. & Nash, T. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187, 1941-1951 (1998).
11. Ahmed, R., Jamieson, B.D. & Porter, D.D. Immune therapy of a persistent and disseminated viral infection. J. Virol. 61, 3920-3929 (1987).
12. Zhang, H. et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N. Engl. J. Med. 339, 1803-1809 (1998).
13. Marras, D. et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat. Med. 8, 522-526 (2002).
14. Flodstrom, M. et al. Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 3, 373-382 (2002).
15. Lang, K.S. et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11, 138-145 (2005).
16. Wolf, D.G. et al. Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood 101, 463-465 (2003).
17. Lichterfeld, M. et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J. Exp. Med. 200, 701-712 (2004).
18. Matloubian, M., Concepcion, R.J. & Ahmed, R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8056-8063 (1994).
19. Grakoui, A. et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 302, 659-662 (2003).
20. Kiepiela, P. et al. CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13, 46-53 (2007).
21. Thomson, M. et al. The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity. J. Virol. 77, 862-870 (2003).
22. Bronke, C., Westerlaken, G.H., Miedema, F., Tesselaar, K. & van Baarle, D. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells. Immunol. Lett. 97, 215-224 (2005).
23. Sousa, A.E., Carneiro, J., Meier-Schellersheim, M., Grossman, Z. & Victorino, R.M. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169, 3400-3406 (2002).
24. Silvestri, G. et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18, 441-452 (2003).
25. Kobasa, D. et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445, 319-323 (2007).
26. Lo, A.W., Tang, N.L. & To, K.F. How the SARS coronavirus causes disease: host or organism? J. Pathol. 208, 142-151 (2006).
27. Staprans, S.I. et al. Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein. Proc. Natl. Acad. Sci. USA 101, 13026-13031 (2004).
28. Recher, M. et al. Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat. Immunol. 5, 934-942 (2004).
29. Matter, M., Odermatt, B., Yagita, H., Nuoffer, J.M. & Ochsenbein, A.F. Elimination of chronic viral infection by blocking CD27 signaling. J. Exp. Med. 203, 2145-2155 (2006).
30. Oxenius, A., Bachmann, M.F., Zinkernagel, R.M. & Hengartner, H. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28, 390-400 (1998).
31. Harada, Y., Muramatsu, M., Shibata, T., Honjo, T. & Kuroda, K. Unmutated immunoglobulin M can protect mice from death by influenza virus infection. J. Exp. Med. 197, 1779-1785 (2003).
32. Wang, X.Z. et al. Virus-specific CD8 T cells in peripheral tissues are more resistant to apoptosis than those in lymphoid organs. Immunity 18, 631-642 (2003).
33. Hangartner, L. et al. Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies. Proc. Natl. Acad. Sci. USA 100, 12883-12888 (2003).
34. Legrand, E. et al. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients. AIDS Res. Hum. Retroviruses 13, 1383-1394 (1997).
35. Andreansky, S. et al. The limits of protection by "memory" T cells in Ig-/- mice persistently infected with a gamma-herpesvirus. Proc. Natl. Acad. Sci. USA 101, 2017-2022 (2004).
36. Crotty, S., McCausland, M.M., Aubert, R.D., Wherry, E.J. & Ahmed, R. Hypogamma-globulinemia and exacerbated CD8 T cell mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease. Blood 108, 3085-3093 (2006).
37. Planz, O. et al. A critical role for neutralizing-antibody- producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94, 6874-6879 (1997).
38. Lauterbach, H., Truong, P. & McGavern, D.B. Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification. Virol. J. 4, 53 (2007).
39. Allen, T.M. et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407, 386-390 (2000).
40. Ramos-Casals, M. et al. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma. J. Rheumatol. 31, 495-499 (2004).
41. Oxenius, A. et al. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Proc. Natl. Acad. Sci. USA 99, 13747-13752 (2002).
42. Battegay, M. et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33, 191-198 (1991).
43. Junt, T. et al. Antiviral immune responses in the absence of organized lymphoid T cell zones in plt/plt mice. J. Immunol. 168, 6032-6040 (2002).